Insider trades
David Michael Johnson, Director of Zentalis Pharmaceuticals ZNTL, has filed 14 purchases and 0 sales on the open market. The latest trade was on 06/16.
David Michael Johnson
Director
- First filing
- 23/01/09
- Trades
- 26 trades
- Buys / sales
- 14 / 0
- 12-month net buying
- No record
- Last trade
- 06/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Aura BiosciencesAURA | Open-market buy | 25/05/16 | 25/05/20 | 20,000 sh | $4.90 | $98,000 | +13.7% |
| Open-market buy | 23/11/10 | 23/11/13 | 17,000 sh | $9.88 | $167,960 | +13.3% | |
| Open-market buy | 23/11/07–23/11/08 | 23/11/09 | 199,601 sh6 trades | $7.19avg. | $1,434,987.3 | No record | |
| Open-market buy | 23/10/03–23/10/04 | 23/10/05 | 20,066 sh2 trades | $8.38avg. | $168,178.26 | +66.9% | |
| Open-market buy | 23/01/05–23/01/06 | 23/01/09 | 2,000 sh4 trades | $10.41avg. | $20,811.04 | +12.5% |